0
Business
India drugs regulator flags Eli Lilly obesity ads, campaign put on hold
May 12, 2026
Scroll
Posted 2 hours ago by
The campaign, titled “We Know Now,” was launched in mid-2025 following the introduction of Lilly’s GLP-1 drug Mounjaro for obesity and diabetes.
The Hindu BusinessLine
Coverage and analysis from India. All insights are generated by our AI narrative analysis engine.
India
Bias: lean right